Androgens in Women: Hormone-Modulating Therapies for Androgen-Mediated Cutaneous Disorders

    Sarah Azarchi, Amanda Bienenfeld, Kristen Lo Sicco, Shari Marchbein, Jerry Shapiro, Arielle R. Nagler
    Image of study
    TLDR Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.
    The document from June 2019 reviews hormone-modulating therapies for androgen-mediated cutaneous disorders (AMCDs) in women, such as acne, hirsutism, and female pattern hair loss (FPHL). It discusses the efficacy, safety, and mechanisms of various treatments, including combined oral contraceptives (COCs), spironolactone, finasteride, dutasteride, and flutamide. COCs are FDA-approved for acne and are as effective as antibiotics after 6 months, while spironolactone is used off-label for acne and hirsutism but lacks high-quality evidence. Flutamide is effective for hirsutism but carries a risk of hepatotoxicity and is not recommended as first-line therapy. For FPHL, minoxidil is the only FDA-approved treatment, with other drugs used off-label. The document notes that flutamide is the most effective for hirsutism but not first-line due to hepatotoxicity, and while dutasteride is superior to finasteride in men, it lacks RCTs in women for FPHL. The importance of a 6-month trial, periodic monitoring, and contraception for women of child-bearing age on these treatments is emphasized, along with the need for more rigorous studies to evaluate these therapies for AMCDs.
    Discuss this study in the Community →

    Research cited in this study

    56 / 56 results

    Related Community Posts Join

    6 / 1000+ results

      community Any treatment not nuking systemic DHT levels?

      in Finasteride/Dutasteride  16 upvotes 1 week ago
      Hair loss treatments that avoid significantly lowering systemic DHT levels, focusing on topical options like dutasteride mesotherapy, minoxidil, and ketoconazole. The user is exploring alternatives like KX-826 and RU58841 due to concerns about hormone levels.

      community Hair loss research is a money grab

      in Chat  227 upvotes 3 months ago
      Hair loss is linked to DHT, with treatments like finasteride and minoxidil being common but not definitive. Economic interests influence research, and there is potential for new treatments like PP405 and RU58841.

      community Occipitalis Muscle Tension Theory

      in Treatment  8 upvotes 4 weeks ago
      Scalp tension from the occipitalis muscle is theorized to contribute to hair loss, but most believe DHT and genetics are the main causes. Treatments like finasteride and minoxidil are considered more effective than addressing scalp tension.

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

      in Research/Science  126 upvotes 2 years ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

    Similar Research

    5 / 1000+ results